Literature DB >> 19602776

Propylthiouracil attenuates monocrotaline-induced pulmonary arterial hypertension in rats.

Cheuk-Kwan Sun1, Chun-Man Yuen, Ying-Hsien Kao, Li-Teh Chang, Sarah Chua, Jiunn-Jye Sheu, Chia-Hung Yen, Sheung-Fat Ko, Hon-Kan Yip.   

Abstract

BACKGROUND: Propylthiouracil (PTU) enhances nitric oxide production and inhibits smooth muscle cell proliferation, suggesting a possible role in the prevention of pulmonary arterial hypertension (PAH). METHODS AND
RESULTS: The 30 male Sprague-Dawley rats were randomized to receive saline injection only (group 1), monocrotaline (MCT) (70 mg/kg) only (group 2) or MCT + 0.1% PTU in drinking water (group 3) given on day 5 after MCT administration. By day 35, western blot showed lower connexin43 (Cx43) and membranous protein kinase C-epsilon expressions in the right ventricle (RV) of group 2 animals than in the other groups (all P<0.05). Conversely, Cx43 expression in the lung was higher in group 2 than in other groups (all P<0.02). Additionally, mRNA expressions of matrix metalloproteinase-9, tissue necrotic factor-alpha, and caspase-3 were higher, whereas Bcl-2 and endothelial nitric oxide synthase were lower, in the lungs and RV of group 2 rats than in the other groups (all P<0.05). Moreover, the numbers of alveolar sacs and lung arterioles were also reduced in group 2 than in other groups (all P<0.05), and RV systolic pressure and RV weight were increased in group 2 compared with other groups (all P<0.001).
CONCLUSIONS: PTU effectively attenuates complications associated with MCT-induced PAH.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19602776     DOI: 10.1253/circj.cj-09-0074

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

1.  Long-term research of stem cells in monocrotaline-induced pulmonary arterial hypertension.

Authors:  Yun Luan; Xue Zhang; Tong-Gang Qi; Guang-Hui Cheng; Chao Sun; Feng Kong
Journal:  Clin Exp Med       Date:  2013-08-31       Impact factor: 3.984

2.  Therapeutic effect of rosuvastatin and propylthiouracil on ameliorating high-cholesterol diet-induced fatty liver disease, fibrosis and inflammation in rabbit.

Authors:  Pao-Yuan Lin; Chih-Hung Chen; Christopher Glenn Wallace; Kuan-Hung Chen; Chia-Lo Chang; Hong-Hwa Chen; Pei-Hsun Sung; Kun-Chen Lin; Sheung-Fat Ko; Cheuk-Kwan Sun; Hsueh-Wen Chang; Pei-Lin Shao; Mel S Lee; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 3.  Importance of Cx43 for Right Ventricular Function.

Authors:  Kerstin Boengler; Susanne Rohrbach; Norbert Weissmann; Rainer Schulz
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

4.  Identifying Potential Mitochondrial Proteome Signatures Associated with the Pathogenesis of Pulmonary Arterial Hypertension in the Rat Model.

Authors:  Jie Wang; Md Nazim Uddin; Qian Li; Alidan Aierken; Ming-Yuan Li; Rui Wang; Qian-Zhi Yan; Dilare Adi; Ming-Tao Gai; Yun Wu
Journal:  Oxid Med Cell Longev       Date:  2022-02-21       Impact factor: 6.543

5.  Propylthiouracil Attenuates Experimental Pulmonary Hypertension via Suppression of Pen-2, a Key Component of Gamma-Secretase.

Authors:  Ying-Ju Lai; Gwo-Jyh Chang; Yung-Hsin Yeh; Jong-Hwei S Pang; Chung-Chi Huang; Wei-Jan Chen
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

6.  HIF-1α promotes the proliferation and migration of pulmonary arterial smooth muscle cells via activation of Cx43.

Authors:  Xiao-Jian Han; Wei-Fang Zhang; Qin Wang; Min Li; Chun-Bo Zhang; Zhang-Jian Yang; Ren-Jie Tan; Li-Jun Gan; Le-Ling Zhang; Xue-Mei Lan; Fang-Lin Zhang; Tao Hong; Li-Ping Jiang
Journal:  J Cell Mol Med       Date:  2021-10-26       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.